Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“All the data are consistent with the hypothesis that enhanced inhibitory effects of adenosine explain the diminished ability of beta adrenergic agonists to activate lipolysis.”
The Journal of clinical investigation • 1984 | View Paper
“The ability of these beta adrenergic blocking agents to inhibit cyclic 39, 59-adenosine monophosphate (39, 59-AMP)-stimulated glycogenolysis and lipolysis may be related to their modification of Ca ++ transport across the membranes.”